GC Pharma: Individuals Net Sell 255,879 Shares Over 5 Days... Stock at 496,500 KRW (-1.68%)

As of 10:31 a.m. on January 27, GC Pharma is trading at 496,500 KRW, down 1.68% from the previous day. Trading volume stands at 255,869 shares, which is 15.98% of the previous day's volume. GC Pharma is known as a pharmaceutical company specializing in blood products and vaccines.

On January 25, Sun Minjeong, a researcher at Hana Financial Investment, stated, "With the initial shipment of Hunterase, which was approved in China in September last year, expected in the first quarter, exports of Hunterase in 2021 are anticipated to nearly double compared to the previous year. Southern Hemisphere influenza vaccines recorded about 40 billion KRW in 2020, and, as concerns over a twindemic have grown in the Southern Hemisphere just as in the Northern Hemisphere last fall, demand for flu vaccines is also expected to increase. As exports of products developed or manufactured in-house rise, profitability is expected to improve significantly." She set GC Pharma's target price at 500,000 KRW.

Over the past five days, individual investors have made a net sale of 255,879 shares of GC Pharma, while foreign investors and institutions have made net purchases of 235,078 shares and 30,226 shares, respectively.

※ Source: AI Investment Assistant AI Rassiro

※ This article was automatically generated in real time by a news automation algorithm jointly developed by Asia Economy and the financial AI company Thinkpool.

This content was produced with the assistance of AI translation services.